Artículos relacionados
Avelumab to treat Merkel cell carcinoma: real-life experience in a dedicated oncology center
The arrival of immunotherapy has revolutioned the management of patients with metastatic Merkel cell carcinoma (MCC). We conducted an observational, retrospective study of 14 cases treated with avelumab. The response rate was 57%: complete response […]
Exonic variants of the P2RX7 gene in familial multiple sclerosis
Introduction Several studies have analysed the presence of P2RX7 variants in patients with MS, reporting diverging results. Methods Our study analyses P2RX7 variants detected through whole-exome sequencing (WES). Results We analysed P2RX7, P2RX4, and CAMKK2 […]
BCGitis: Absceso pélvico por Mycobacterium bovis BCG posterior a inmunoterapia en cáncer de vejiga. Reporte de un caso
La inmunoterapia con el bacilo de Calmette-Guérin (BCG) para el cáncer de vejiga no musculo-invasor corresponde al estándar de tratamiento adyuvante posterior a la resección transuretral. A pesar de su efectividad y seguridad, alrededor de […]
